Utility of Serial BNP Levels in Emergency Department CHF
Completed
Conditions studied: Congestive Heart Failure
In brief
The purpose of the study is to determine if a series of BNP blood tests performed on patients who present to the Emergency Department with congestive heart failure (CHF) can predict which patients may have adverse outcomes. If the BNP is shown to be predictive of bad outcomes in certain patients, those patients might receive more intensive therapy early to prevent such outcomes. This was a prospective trial enrolling patients who presented to the ED and were diagnosed with heart failure. Subjects had a blood test for BNP, which is elevated in the presence of heart failure, collected twelve hours after their initial clinical BNP was obtained in the ED. Demographics, history, length of hospital stay, and other approved data were collected. At 30 days and 6 months after discharge, a follow up call was made to determine if the subject had required additional emergency care, had been admitted to a hospital, or had died during that period of time.
Key facts
- Study ID
- NCT00534066
- Run by
- Ohio State University
- People needed
- 52
- Starts
- 2002-09-01
- Expected to finish
- 2006-06-01
- Last updated by the study team
- 2007-09-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age18 or older
- primary diagnosis of CHF in the Emergency Department
- admission to the hospital or transfer to the Observation Unit
You may not qualify if…
- minors, prisoners,pregnant women,unable to provide consent
- unstable angina or acute myocardial infarction in the ED
- dialysis dependent patients
- use of nesiritide as a therapy in the ED
Where it is running
- The Ohio State University Medical Center — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.